The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Profiling of 1,350 neuroendocrine tumors for identification of multiple potential drug targets.
Igor A. Astsaturov
Consultant or Advisory Role - Caris Life Sciences
Honoraria - Caris Life Sciences
Steven J. Cohen
Honoraria - Caris Life Sciences
Paul F. Engstrom
No relevant relationships to disclose
Sherri Z. Millis
Employment or Leadership Position - Caris Life Sciences